# A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer

> **NCT01194427** · PHASE2 · TERMINATED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 2 (actual)

## Conditions studied

- Stage I Breast Cancer
- Stage II Breast Cancer
- Stage III Breast Cancer
- Invasive Breast Cancer

## Interventions

- **DRUG:** Vorinostat and Tamoxifen

## Key facts

- **NCT ID:** NCT01194427
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-03
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Difficulty meeting patient accrual goals
- **Last updated:** 2013-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01194427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01194427, "A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01194427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*